Integrative Group-based Cognitive Rehabilitation Efficacy in Multiple Sclerosis: a Randomized Clinical Trial

CompletedNot a drug-phase studyRelapsing and progressiveNCT02287454

What it found

No results found

We found no results in the registry or in papers.

This trial finished 13 years ago. We found no results in the registry or in any paper that cites it.

What was tested

Treatment tested

  • cognitive remediation program: REHACOP

What it measured

Main measures

  • Change in attention after receiving cognitive rehabilitation treatment

    3 months

    Thinking and memory
  • Change in working memory after receiving cognitive remediation treatment

    3 months

    Thinking and memory
  • Change in processing speed after receiving cognitive remediation treatment

    3 months

    Thinking and memory
  • Change in verbal memory after receiving cognitive remediation treatment

    3 months

    Thinking and memory
  • Change in verbal fluency after receiving cognitive remediation treatment

    3 months

    Thinking and memory
  • Change in executive functioning after receiving cognitive remediation treatment.

    3 months

    Thinking and memory

Who could take part

Relapsing and progressive · 20 to 60

Show the full criteria

Inclusion criteria

i) age 20-60 years ii) either male or female iii) patients with relapsing-remitting, secondary progressive or primary progressive MS

Exclusion criteria

i) presence of dementia ii) have suffered an exacerbation during the previous month to the cognitive assessment iii) being treated with corticosteroids iv) presence of other neurological disorder v) history of stroke or traumatic brain injury resulting in more than 30 minutes loss of consciousness vi) presence of psychiatric disorders

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

The study design was a parallel-group randomized trial with equal randomization. Recruitment and enrollment were conducted between January 2013 and March 2013. At base-line, cognitive data was collected. Afterwards, the participants were randomly allocated to either the REHACOP group or the Control group. During 3 months the intervention with REHACOP program took place and at follow-up patients were again re-evaluated to evaluate the change in cognitive measure. Post-treatment assessment (finished by July 2013) was performed within the first week after completing the intervention. Optional enrollment in pre-post neuroimaging will also allow us to look at changes in the brain. Objective: To examine the efficacy of an integrative cognitive training program (REHACOP) to improve cognition of patients with Multiple Sclerosis (MS).

Loading reviews and guidelines…

History

    1. Started

      Jan 2013

    2. Main results due

      Jul 2013

    3. Finished

      Jul 2013

    Assembled by software from public sources.